These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 17436551)

  • 1. Highly sensitive target-based whole-cell antibacterial discovery strategy by antisense RNA silencing.
    Singh SB; Phillips JW; Wang J
    Curr Opin Drug Discov Devel; 2007 Mar; 10(2):160-6. PubMed ID: 17436551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening strategies for discovery of antibacterial natural products.
    Singh SB; Young K; Miesel L
    Expert Rev Anti Infect Ther; 2011 Aug; 9(8):589-613. PubMed ID: 21819327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of bacterial fatty acid synthase inhibitors from a Phoma species as antimicrobial agents using a new antisense-based strategy.
    Ondeyka JG; Zink DL; Young K; Painter R; Kodali S; Galgoci A; Collado J; Tormo JR; Basilio A; Vicente F; Wang J; Singh SB
    J Nat Prod; 2006 Mar; 69(3):377-80. PubMed ID: 16562839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Staphylococcus aureus fitness test platform for mechanism-based profiling of antibacterial compounds.
    Donald RG; Skwish S; Forsyth RA; Anderson JW; Zhong T; Burns C; Lee S; Meng X; LoCastro L; Jarantow LW; Martin J; Lee SH; Taylor I; Robbins D; Malone C; Wang L; Zamudio CS; Youngman PJ; Phillips JW
    Chem Biol; 2009 Aug; 16(8):826-36. PubMed ID: 19716473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitors of FabI, an enzyme drug target in the bacterial fatty acid biosynthesis pathway.
    Lu H; Tonge PJ
    Acc Chem Res; 2008 Jan; 41(1):11-20. PubMed ID: 18193820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of antibacterial mechanism of action using regulated antisense RNA expression in Staphylococcus aureus.
    Ji Y; Yin D; Fox B; Holmes DJ; Payne D; Rosenberg M
    FEMS Microbiol Lett; 2004 Feb; 231(2):177-84. PubMed ID: 14987762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation, structure, and absolute stereochemistry of platensimycin, a broad spectrum antibiotic discovered using an antisense differential sensitivity strategy.
    Singh SB; Jayasuriya H; Ondeyka JG; Herath KB; Zhang C; Zink DL; Tsou NN; Ball RG; Basilio A; Genilloud O; Diez MT; Vicente F; Pelaez F; Young K; Wang J
    J Am Chem Soc; 2006 Sep; 128(36):11916-20. PubMed ID: 16953632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platensimycin is a selective FabF inhibitor with potent antibiotic properties.
    Wang J; Soisson SM; Young K; Shoop W; Kodali S; Galgoci A; Painter R; Parthasarathy G; Tang YS; Cummings R; Ha S; Dorso K; Motyl M; Jayasuriya H; Ondeyka J; Herath K; Zhang C; Hernandez L; Allocco J; Basilio A; Tormo JR; Genilloud O; Vicente F; Pelaez F; Colwell L; Lee SH; Michael B; Felcetto T; Gill C; Silver LL; Hermes JD; Bartizal K; Barrett J; Schmatz D; Becker JW; Cully D; Singh SB
    Nature; 2006 May; 441(7091):358-61. PubMed ID: 16710421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery and antibacterial activity of glabramycin A-C from Neosartorya glabra by an antisense strategy.
    Jayasuriya H; Zink D; Basilio A; Vicente F; Collado J; Bills G; Goldman ML; Motyl M; Huber J; Dezeny G; Byrne K; Singh SB
    J Antibiot (Tokyo); 2009 May; 62(5):265-9. PubMed ID: 19343064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of FabH/FabF inhibitors from natural products.
    Young K; Jayasuriya H; Ondeyka JG; Herath K; Zhang C; Kodali S; Galgoci A; Painter R; Brown-Driver V; Yamamoto R; Silver LL; Zheng Y; Ventura JI; Sigmund J; Ha S; Basilio A; Vicente F; Tormo JR; Pelaez F; Youngman P; Cully D; Barrett JF; Schmatz D; Singh SB; Wang J
    Antimicrob Agents Chemother; 2006 Feb; 50(2):519-26. PubMed ID: 16436705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel targets for the future development of antibacterial agents.
    McDevitt D; Payne DJ; Holmes DJ; Rosenberg M
    Symp Ser Soc Appl Microbiol; 2002; (31):28S-34S. PubMed ID: 12481826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploiting current understanding of antibiotic action for discovery of new drugs.
    Chopra I; Hesse L; O'Neill AJ
    Symp Ser Soc Appl Microbiol; 2002; (31):4S-15S. PubMed ID: 12481824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel targets for the future development of antibacterial agents.
    McDevitt D; Payne DJ; Holmes DJ; Rosenberg M
    J Appl Microbiol; 2002; 92 Suppl():28S-34S. PubMed ID: 12000610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coniothyrione, a chlorocyclopentandienylbenzopyrone as a bacterial protein synthesis inhibitor discovered by antisense technology.
    Ondeyka JG; Zink D; Basilio A; Vicente F; Bills G; Diez MT; Motyl M; Dezeny G; Byrne K; Singh SB
    J Nat Prod; 2007 Apr; 70(4):668-70. PubMed ID: 17346074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tackling antibiotic resistance: a dose of common antisense?
    Woodford N; Wareham DW;
    J Antimicrob Chemother; 2009 Feb; 63(2):225-9. PubMed ID: 19004840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multivalent approach to drug discovery for novel antibiotics.
    Long DD; Aggen JB; Christensen BG; Judice JK; Hegde SS; Kaniga K; Krause KM; Linsell MS; Moran EJ; Pace JL
    J Antibiot (Tokyo); 2008 Oct; 61(10):595-602. PubMed ID: 19168973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. When will the genomics investment pay off for antibacterial discovery?
    Mills SD
    Biochem Pharmacol; 2006 Mar; 71(7):1096-102. PubMed ID: 16387281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation, structure, and antibacterial activities of lucensimycins D-G, discovered from Streptomyces lucensis MA7349 using an antisense strategy.
    Singh SB; Zink DL; Dorso K; Motyl M; Salazar O; Basilio A; Vicente F; Byrne KM; Ha S; Genilloud O
    J Nat Prod; 2009 Mar; 72(3):345-52. PubMed ID: 19115838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic approaches to antibacterial discovery.
    Payne DJ; Gwynn MN; Holmes DJ; Rosenberg M
    Methods Mol Biol; 2004; 266():231-59. PubMed ID: 15148422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postgenomic strategies in antibacterial drug discovery.
    Brötz-Oesterhelt H; Sass P
    Future Microbiol; 2010 Oct; 5(10):1553-79. PubMed ID: 21073314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.